About ECR

European Cardiology Review (ECR) is an international, English-language, peer-reviewed journal that publishes articles continuously on ECRjournal.com. It aims to assist time-pressured physicians to stay abreast of key advances and opinions in the area of cardiovascular disease.

The journal comprises balanced and comprehensive review articles written by leading authorities. The journal provides updates on a range of salient issues to support physicians in developing their knowledge and effectiveness in day-to-day clinical practice.

The journal endeavours to support the continuous medical education of specialist and general cardiologists and disseminate knowledge of the field to the wider cardiovascular community.

Led by Editor-in-Chief Juan Carlos Kaski, along with Associate Editors Pablo Avanzas and Bianca Rocca, and an editorial board of world-renowned physicians, the Journal publishes peer-reviewed articles that aim to provide timely updates on the most pertinent issues in the field.

For information on submitting an article, please contact Ola Wisniewska, ola.wisniewska@radcliffe-group.com.

One volume per year under a continuous publishing model.

Print ISSN: 1758-3756 Online ISSN: 1758-3764

The journal is abstracted, indexed and listed in PubMed, PubMed Central, Crossref, Emerging Sources Citation Index (ESCI), Scopus and Directory of Open Access Journals (DOAJ). All articles are published in full on PubMed Central a month after publication.

In 2023 the Journal was accepted for inclusion in the Journal Citation Reports list from Clarivate, with a 2024 Journal Impact Factor of 3.2, and ranked 9 out of 69 journals in ESCI’s Cardiac & Cardiovascular Systems list in 2023

European Cardiology Review is an online publication. Articles are published continuously on ECRjournal.com. The journal is free to view online and is available for download in PDF format to registered users. Print subscriptions are available upon request.

The journal consists of review articles, original research, meta-analyses, systematic reviews, editorials, expert opinions and letters to the editor.

The journal is guided by the Editor-in-Chief, supported by an Associate Editor and an Editorial Board, who are all recognised experts in their fields.

All submissions are subject to initial appraisal by the Editor in Chief, and, if found suitable for further consideration, sent forward for peer review by independent, anonymous expert referees. All peer review is double blind and submission is online via Editorial Manager.

ECR has an official partnership with the International Society of Cardiovascular Pharmacotherapy (ISCP). A 50% Article Publication Charge (APC) waiver for unsolicited articles is available for ISCP members.

The publisher is a member of Crossref, the STM and the Association of Learned and Professional Society Publishers (ALPSP).

Radcliffe Cardiology provides free educational content to cardiologists and allied healthcare professionals via our gold open access publishing model. To support open access publication costs, Radcliffe Cardiology and Radcliffe Vascular charge an Article Publication Charge (APC) to authors upon acceptance of an unsolicited paper. More details on these charges and associated waivers can be found on the For Authors page.

The vast majority of our content is editorially independent, developed at our own cost. However, we do collaborate and receive funding from select industry partners in the following ways; all sources of such funding are fully declared on all these materials:

• Adverts at the front and back of the journals (never within the journal text)
• Web advertising
• Interstitial adverts
• Pre-roll video adverts (as pre-cursors to our independent content)
• Promotional/supplemental content (published as supplements to our peer-reviewed journals)
• Supported webinars, roundtable discussions, video interviews and live cases
• Continuing medical education activities.

We invite authors wishing to discuss potential submission to contact ola.wisniewska@radcliffe-group.com for further details.

We invite contributions from leading authorities who are identified by the Editor-in-Chief and/or with the support of the Section Editors and guidance from the Editorial Board. Following acceptance of an invitation, the authors and Publisher, in conjunction with the Editor-in-Chief, formalise the working title and scope of the article. The Publisher will provide further information and submission instructions.

We welcome unsolicited contributions which are assessed by the Editor-in-Chief for suitability and relevance prior to peer review.

The journal is always keen to hear from leading authorities wishing to discuss potential submissions. Please contact ola.wisniewska@radcliffe-group.com for further details or review the author guidelines here.

Reprints of all published articles are available to authors, institutions and commercial organisations. For commercial reprint and permission enquiries please contact Springer Healthcare (ReprintsWarehouse@springernature.com). For non-commercial reprints and permissions enquiries, please visit Copyright.com to start a request. For author reprints, please email Rob Barclay (rob.barclay@radcliffe-group.com).

We protect an individual's data and will not publish any author or patient data that might identify an individual without their written and informed consent. For detailed information on our data-sharing policy please click here and for information on our company privacy statements, please click here.

Duty of Publisher

The journal follows the International Committee of Medical Journals (ICMJE) recommendations and the Committee on Publication Ethics (COPE) best practice guidelines. We expect all parties involved in journal publication, including editors, authors and reviewers, to follow these guidelines to their best endeavours.

Key points are below, and further information can be found in the Information for Authors/Author Guidelines.

Publication Decisions and Peer Review

Duty of Editors

Our editors and editors-in-chief aim to meet the needs of readers and authors and act independently from the journal publisher without prejudice. They make editorial decisions based on the quality and suitability of the submitted work for the journal and not for any political or financial gain and without regard for an author’s race, sex, religious beliefs or sexual orientation. Submitted content undergoes double-blind peer review from two experts before being considered for publication. Each individual journal's editor-in-chief is responsible for accepting content to be published in that journal.

We strongly suggest that all submissions have been approved by an appropriate body, such as the Research Ethics Committee prior to publication.

Duty of Authors

Authors acknowledge that when they submit a manuscript it will be subject to peer review. They are obliged to respond promptly to an editor’s requests for additional information and to address reviewer comments in a timely manner, resubmitting their manuscript where necessary, in the required timeframes.

We strongly suggest that all submissions have been approved by an appropriate body, such as the Research Ethics Committee, prior to submission.

Duty of Reviewers

Peer reviewers are required to respond promptly to invitations and to review manuscripts in the timeframes set by the editor.

Confidentiality

Duty of Publisher and Editors

The publisher and editors treat all submissions as confidential documents. They do not disclose information regarding the author of a submitted manuscript during peer reviews, which is conducted double-blind. They will never share a submitted manuscript with a reviewer unless they have accepted the invitation to review.

Duty of Reviewers

All manuscripts submitted will be treated in peer review confidentially. No information on the author will be disclosed during peer review. Ideas expressed in submitted manuscripts are to be kept confidential by reviewers and will not be used elsewhere by the editor or reviewer without prior written consent from the author.

Misconduct and Ethical Malpractice

Duty of Publisher

The publisher takes reasonable steps to identify and prevent the publication of papers where misconduct has occurred. In no case shall we as the publisher encourage or knowingly allow such misconduct to take place. The publisher follows the COPE flowcharts when dealing with such instances.

We reserve the right to reverse the decision to accept a submission where we believe our editorial policies have been infringed. Papers suspected of ethical malpractice or misconduct will not be considered for publication. We reserve the right to inform the author’s co-authors and/or institution/regulatory body when such instances occur.

Duty of Editors

We take reasonable steps to identify and prevent the publication of papers where ethical concerns, misconduct, or malpractice has occurred. The editors will never encourage or knowingly allow misconduct or malpractice to take place to published or unpublished papers and follow the COPE flowcharts when dealing with such instances.

Duplication and Plagiarism

Duty of the Publisher and Editors

Plagiarism is not accepted and considered unethical publishing. Our journals use similarity checking software to detect unoriginal material and to avoid plagiarism and duplication. Where plagiarism or duplication is highlighted, the concerns will be raised with the author and the manuscript will be rejected.

It is unethical to submit a manuscript to more than one journal at a time. Where this occurs the concern will be raised with the author and the manuscript will be rejected. In certain circumstances, a secondary publication may be permitted under terms agreed between publishers. The primary reference must be cited in the secondary publication.

Duty of Authors

Authors should provide original work and should adequately reference and cite any works of others they have used for the purposes of review. Authors are not permitted to copy, reuse or paraphrase work from others without adequately citing.

Duty of Reviewers

Reviewers should notify the editor if they are aware of substantial similarity or duplication of content between the submitted manuscript and previously published works.

Research Data

Duty of Publisher and Editors

We do not permit the manipulation of research data through data falsification or data fabrication. Where data falsification or fabrication is suspected, the concerns will be raised with the author. We reserve the right to inform the author’s co-authors and/or institution/regulatory body when such instances occur.

Errors, Omissions and Retractions

Duty of Publisher and Editors

We take strive to ensure the academic integrity of our journals and to ensure that all content is reproduced correctly. However, we cannot guarantee the accuracy, adequacy or completeness of the information and cannot be held responsible for any errors or omissions, or for the results obtained from the use thereof. Occasionally, circumstances may arise where an article is published that must be retracted or removed. Any errors should be reported to the journal’s managing editor for investigation. We commit to retract, correct and apologise for any inaccuracies or misleading statements with due prominence through errata and corrigenda. In all cases, our archives at the British Library and the Agency for the Legal Deposit Libraries retain all versions.

Duty of Authors

Authors have a duty to report perceived errors or omissions in their work to the publisher. An error that is reported and is the fault of the author will be published as a corrigendum as promptly as possible.

Complaints and Appeals

Duty of Publisher and Editors

Any complaints should be first directed in writing to the editorial office and managing editor of the journal. If the editorial office or managing editor is the subject of the complaint, please raise this with the publisher. The publisher will aim to deal with any complaints or allegations of misconduct as appropriately and as swiftly as possible. If not resolved satisfactorily, any complaints can be passed to the overseeing body or ombudsmen where one exists. A complaint may be referred to COPE within 6 months if it cannot be resolved through the journal's complaints procedure and only if it pertains to procedural complaints rather than editorial content.

Declarations: Conflict of Interest and Intellectual Property

A conflict of interest exists when an opinion may be influenced or biased by a secondary interest, such as financial gain. Conflicts of interest may occur from commercial or financial interests, such as research funding, consultancy services, serving on speakers’ bureaux, travel expenses, appearance fees, the receipt of share options, or direct employment by a commercial entity. they may also occur from personal relationships, beliefs or rivalries.

All authors, peer reviewers, and editors must declare any conflicts of interest pertaining to the article when submitting a manuscript. All sources of support for the work where a conflict exists will be published. Conversely, authors should state clearly where there are no conflicts of interest to declare. Peer reviewers are asked to make the same declarations.

Duty of Publisher

We make it clear in our publications where any conflicts of interest occur and inform readers when research has been funded. A disclosure statement appears on every manuscript published within the journal. The purpose of this statement is to provide readers of the manuscript with information about any author interests that could influence how readers receive and understand the work.

Duty of Editors

Editorial staff employed by or contracted to Radcliffe Group, including editors-in-chief and guest editors, will not handle manuscripts where they have a potential conflict of interest. In such instances, an alternative member of the editorial staff or an alternative editorial board member will handle the manuscript.

Duty of Authors

The authors must complete the questions asked in our electronic submission system (Editorial Manager), which follows the ICMJE recommendations. These answers will be stored, and a disclosure statement will appear on every manuscript published within the journal based on the authors' responses. The purpose of this statement is to provide readers of the manuscript with information about the authors’ interests that could influence how they receive and understand the work. For more information and to download a Form for Disclosure of Potential Conflicts of Interest, which can be submitted with a manuscript, please visit: www.icmje.org/conflicts-of-interest/

Acknowledgements: Author(s) should acknowledge substantive contributions to the article, including receipt of financial assistance, materials, and other resources.

Informed Consent: Authors should include a statement in the manuscript that informed consent was obtained if experimentation with human subjects was conducted. The privacy rights of human subjects must always be observed. For more information, please see our Author Guidelines. 

Human and Animal Rights: If the work involves the use of animal or human subjects, this should be clearly identified in the manuscript. The authors should ensure that the work described has been carried out in accordance with the World Medical Association (Declaration of Helsinki) Ethical Principals for research involving humans, or the EU Directive 2010/63/EU for animal experiments. Where human informed consent has been obtained, this must be included in a supporting statement.

Duty of Reviewers

Reviewers must declare any conflicts of interest before conducting a peer review of a manuscript. Reviewers should decline to review if a potential conflict of interest is present.

Archiving

In the event the journal is no longer published, articles are deposited in digital archives to guarantee their long-term provision. These include:

PubMed Central

The British Library

The Agency for Legal Deposit Libraries

Journal metrics can be a useful tool to assess a journal's performance and for our readers and authors who are considering submitting to our journal. Metrics should not be used in isolation but as an indicator only and we strongly support their use alongside a more qualitative review. Figures are updated annually each year.